Reducing carbon footprint by switching to reusable soft-mist inhalers

Reducing carbon footprint by switching to reusable soft-mist inhalers

Objective Inhalation therapy is the cornerstone of COPD, together with non-pharmacological treatments. Long-acting muscarinic antagonists (LAMAs), alone or in combination with long-acting β-agonists (LABAs), are commonly used. Pressurised metered-dose inhalers (pMDIs), dry powder inhalers (DPIs) and...

Full description

Bibliographic Details
Main Authors: Christer Janson, Jaime Hernando Platz, Stéphane Soulard, Sue Langham, Lindsay Nicholson, Elisabeth Sophia Hartgers-Gubbels
Format: Article
Language:English
Published: European Respiratory Society 2023-05-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/9/3/00543-2022.full

Similar Items

Similar Items